New Blood Test for Colon Cancer Detection

The American Cancer Society announced that the "Shield" blood test, which relies on detecting tumor DNA in the bloodstream, has become an available option among colorectal cancer screening techniques, following its approval by the Food and Drug Administration in 2024. This option aims to provide an alternative for individuals who avoid colonoscopies and stool tests, and it is characterized by a high accuracy in detecting advanced cancers, although it is less sensitive in identifying deterioration before cancer develops.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل